Skip to main content
OpenTrials

Clinical trial condition

Lymphoma, Large B-Cell, Diffuse

Explore clinical trials studying Lymphoma, Large B-Cell, Diffuse. Study availability and eligibility vary by location and protocol.

59 public trials 6 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma, Large B-Cell, Diffuse trial results

Active, not recruiting

LOC-R01 Study of Lenalidomide and Ibrutinib in Association With Rituximab-Methotrexate Procarbazine Vincristin (R-MPV)

NCT04446962

Conditions
Central Nervous System Neoplasms, Central Nervous System Neoplasms, Primary, Hemic and Lymphatic Diseases, +16 more
Locations
  • CHU Amiens Amiens, France
  • CHU Angers Angers, France
  • CH côte Basque Bayonne, France
  • CHU Besançon Besançon, France
View all 28 locations
View Trial Details
Active, not recruiting

Relmacabtagene Autoleucel As Second-Line Therapy in Adult Patients with Aggressive B-cell NHL

NCT06093841

Conditions
Follicular Lymphoma Grade 3B, Hemic and Lymphatic Diseases, High-grade B-cell Lymphoma, +11 more
Locations
  • Sun Yat-sen University Cancer Hospital Guangzhou, Guangdong, China
  • Henan Cancer Hospital Zhengzhou, Henan, China
  • The First Affiliated Hospital of Zhengzhou University Zhengzhou, Henan, China
  • Hunan Cancer Hospital Changsha, Hunan, China
View all 13 locations
View Trial Details
Active, not recruiting

Sepantronium Bromide for the Treatment of High-grade B-cell Lymphoma

NCT05263583

Conditions
Burkitt Lymphoma, C-MYC/BCL2 Double-Hit High-Grade B-Cell Lymphoma, C-MYC/BCL6 Double-Hit High-Grade B-Cell Lymphoma, +24 more
Locations
  • Beijing Cancer Hospital Beijing, China
  • Sun Yat-sen University Cancer Center Guangzhou, China
  • Henan Cancer Hospital Henan, China
  • Shanghai East Hospital Pudong, China
View Trial Details
Completed

A Study of LOXO-305 in Chinese Participants With Blood Cancer (Including Lymphoma and Chronic Leukemia)

NCT04849416

Conditions
Chronic Disease, Disease Attributes, Hematologic Diseases, +19 more
Locations
  • Wannan Medical College Yijishan Hospital Wuhu, Anhui, China
  • Beijing Cancer hospital Beijing, Beijing Municipality, China
  • Southern Medical University Nanfang Hospital Guangzhou, Guangdong, China
  • Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China
View all 22 locations
View Trial Details
Completed

A Trial Comparing the Two High-dose Chemotherapies BeEAM and BEAM Given Before Autologous Stem Cell Transplantation (ASCT) in Lymphoma Patients (BEB-trial)

NCT02278796

Conditions
Dendritic Cell Sarcoma, Interdigitating, Hemic and Lymphatic Diseases, Histiocytic Disorders, Malignant, +13 more
Locations
  • Krankenhaus der Elisabethinen Linz Linz, Austria
  • Hanusch Krankenhaus Wien Vienna, Austria
  • Department for Medical Oncology University Hospital/Inselspital Bern, Switzerland
  • Universitätsspital Zürich Zurich, Switzerland
View Trial Details
Completed

A Safety Trial of Lisocabtagene Maraleucel (JCAR017) for Relapsed and Refractory (R/R) B-cell Non-Hodgkin Lymphoma (NHL) in the Outpatient Setting (TRANSCEND-OUTREACH-007)

NCT03744676

Conditions
Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
Locations
  • Local Institution - 0057 Los Angeles, California, United States
  • Local Institution - 0060 Denver, Colorado, United States
  • Local Institution - 0089 Miami, Florida, United States
  • Local Institution - 0081 Orlando, Florida, United States
View all 23 locations
View Trial Details

Related conditions